These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 16422182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV, O'Brien KL, Bronsdon MA, Madore D, Hackell JG, Reid R, Santosham M.
    Clin Infect Dis; 2007 May 01; 44(9):1173-9. PubMed ID: 17407035
    [Abstract] [Full Text] [Related]

  • 3. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
    Hsieh YC, Lin PY, Chiu CH, Huang YC, Chang KY, Liao CH, Chiu NC, Chuang YC, Chen PY, Chang SC, Liu JW, Yen MY, Wang JH, Liu CY, Lin TY.
    Vaccine; 2009 Sep 04; 27(40):5513-8. PubMed ID: 19615960
    [Abstract] [Full Text] [Related]

  • 4. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.
    Pediatr Infect Dis J; 2009 Apr 04; 28(4):277-82. PubMed ID: 19258924
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 7. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.
    Dinleyici EC, Yargic ZA.
    Expert Rev Vaccines; 2008 Nov 15; 7(9):1367-94. PubMed ID: 18980540
    [Abstract] [Full Text] [Related]

  • 8. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.
    Vaccine; 2007 Jul 20; 25(29):5390-8. PubMed ID: 17583392
    [Abstract] [Full Text] [Related]

  • 9. Pneumococcal vaccines: an update on current strategies.
    Bogaert D, Hermans PW, Adrian PV, Rümke HC, de Groot R.
    Vaccine; 2004 Jun 02; 22(17-18):2209-20. PubMed ID: 15149779
    [Abstract] [Full Text] [Related]

  • 10. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
    Pletz MW, Maus U, Hohlfeld JM, Lode H, Welte T.
    Dtsch Med Wochenschr; 2008 Feb 02; 133(8):358-62. PubMed ID: 18270917
    [Abstract] [Full Text] [Related]

  • 11. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 02; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 12. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.
    Vaccine; 2006 Jul 17; 24(29-30):5690-9. PubMed ID: 16735083
    [Abstract] [Full Text] [Related]

  • 13. Pneumococcal vaccination in adults: does it really work?
    Pitsiou GG, Kioumis IP.
    Respir Med; 2011 Dec 17; 105(12):1776-83. PubMed ID: 21816596
    [Abstract] [Full Text] [Related]

  • 14. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).
    Scheifele D, Halperin S, Pelletier L, Talbot J.
    Clin Infect Dis; 2000 Jul 17; 31(1):58-64. PubMed ID: 10913397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.
    Dinleyici EC, Yargic ZA.
    Expert Rev Vaccines; 2009 Aug 17; 8(8):977-86. PubMed ID: 19627181
    [Abstract] [Full Text] [Related]

  • 17. Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease.
    Hausdorff WP, Dagan R, Beckers F, Schuerman L.
    Vaccine; 2009 Dec 09; 27(52):7257-69. PubMed ID: 19833248
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R.
    Vaccine; 2009 Jul 30; 27(35):4739-40. PubMed ID: 19540951
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 30; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.